Literature DB >> 22888113

The role of the kidney in heart failure.

Marco Metra1, Gad Cotter, Mihai Gheorghiade, Livio Dei Cas, Adriaan A Voors.   

Abstract

Renal dysfunction is common in patients with heart failure and is associated with high morbidity and mortality. Cardiac and renal dysfunction may worsen each other through multiple mechanisms such as fluid overload and increased venous pressure, hypo-perfusion, neurohormonal and inflammatory activation, and concomitant treatment. The interaction between cardiac and renal dysfunction may be critical for disease progression and prognosis. Renal dysfunction is conventionally defined by a reduced glomerular filtration rate, calculated from serum creatinine levels. This definition has limitations as serum creatinine is dependent on age, gender, muscle mass, volume status, and renal haemodynamics. Changes in serum creatinine related to treatment with diuretics or angiotensin-converting enzyme inhibitors are not necessarily associated with worse outcomes. New biomarkers might be of additional value to detect an early deterioration in renal function and to improve the prognostic assessment, but they need further validation. Thus, the evaluation of renal function in patients with heart failure is important as it may reflect their haemodynamic status and provide a better prognostic assessment. The prevention of renal dysfunction with new therapies might also improve outcomes although strong evidence is still lacking.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22888113     DOI: 10.1093/eurheartj/ehs205

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  55 in total

Review 1.  Clinical use of novel biomarkers in heart failure: towards personalized medicine.

Authors:  Daniela Schmitter; Gadi Cotter; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

Review 2.  Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection.

Authors:  Alberto Palazzuoli; Peter A McCullough; Claudio Ronco; Ranuccio Nuti
Journal:  Intern Emerg Med       Date:  2015-05-14       Impact factor: 3.397

Review 3.  Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.

Authors:  Roland E Schmieder; Veselin Mitrovic; Christian Hengstenberg
Journal:  Clin Res Cardiol       Date:  2015-03-19       Impact factor: 5.460

Review 4.  Serelaxin in clinical development: past, present and future.

Authors:  Elaine Unemori
Journal:  Br J Pharmacol       Date:  2017-01-29       Impact factor: 8.739

Review 5.  Relaxin for treatment of acute heart failure: making the case for treating targeted patient profiles.

Authors:  Jaime A Hernandez-Montfort; Sonali Arora; Mara T Slawsky
Journal:  Curr Heart Fail Rep       Date:  2013-09

Review 6.  Heart failure with preserved ejection fraction: a nephrologist-directed primer.

Authors:  Baris Afsar; Patrick Rossignol; Loek van Heerebeek; Walter J Paulus; Kevin Damman; Stephane Heymans; Vanessa van Empel; Alan Sag; Alan Maisel; Mehmet Kanbay
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 7.  Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.

Authors:  Feby Savira; Ruth Magaye; Danny Liew; Christopher Reid; Darren J Kelly; Andrew R Kompa; S Jeson Sangaralingham; John C Burnett; David Kaye; Bing H Wang
Journal:  Br J Pharmacol       Date:  2020-05-13       Impact factor: 8.739

8.  Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.

Authors:  Mauro Gori; Michele Senni; Deepak K Gupta; David M Charytan; Elisabeth Kraigher-Krainer; Burkert Pieske; Brian Claggett; Amil M Shah; Angela B S Santos; Michael R Zile; Adriaan A Voors; John J V McMurray; Milton Packer; Toni Bransford; Martin Lefkowitz; Scott D Solomon
Journal:  Eur Heart J       Date:  2014-06-30       Impact factor: 29.983

Review 9.  Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.

Authors:  Alessia Buglioni; John C Burnett
Journal:  Clin Chim Acta       Date:  2014-10-23       Impact factor: 3.786

10.  Impact of preexisting chronic kidney disease on acute and long-term outcome of critically ill patients on a medical intensive care unit.

Authors:  Pia Lebiedz; Lilli Knickel; Christiane Engelbertz; Florian Lüders; Katrin Gebauer; Wolfgang E Berdel; Johannes Waltenberger; Holger Reinecke
Journal:  J Nephrol       Date:  2013-12-07       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.